Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberdeen Uk Sm. Regulatory News (AUSC)

Share Price Information for Aberdeen Uk Sm. (AUSC)

Share Price is delayed by 15 minutes
Get Live Data
496.00    2.00 (0.40%)
Bid:
493.50
Ask:
497.50
Spread: 4.00 (0.811%)
Market Cap: £228.72m
AUSC Live PriceLast checked at - London Stock Exchange

Intraday Aberdeen Uk Sm. Share Chart

Amendment to Management Fee

3 Apr 2025 07:00

RNS Number : 4110D
abrdn UK Smaller Cos. Growth Trust
03 April 2025
 

3 April 2025

 

abrdn UK Smaller Companies Growth Trust plc

Legal Entity Identifier (LEI): 213800UUKA68SHSJBE37

 

 

Amendment to Management Fee

 

The Board of abrdn UK Smaller Companies Growth Trust plc (the "Company") is pleased to announce that it has agreed a change to the terms of the management fee payable by the Company to Aberdeen Investments ("Aberdeen").

 

With effect from 1 April 2025, the Company's management fee will continue to be charged on a tiered basis, but at reduced rates of 0.60% per annum on the first £200 million of the Net Asset Value ("NAV") and 0.55% on NAV above this figure.

 

Prior to 1 April 2025, the Company's management fee was charged at a rate of 0.75% per annum of the NAV up to £175 million, 0.65% above £175 million and below £550 million, and 0.55% above £550 million.

 

Save for this change, all other terms and conditions contained in the Company's Management Agreement remain unchanged.

 

Liz Airey, Chairman of the Company commented "The Board is pleased to announce this change in the management fee with Aberdeen. We believe that this arrangement will reduce the cost of managing the portfolio by approximately 17.5% per annum to the benefit of all shareholders. As this change is being implemented with only three months of the current financial year left to run, the impact will be more limited in the year to 30 June 2025. However, had the new management fee arrangement been in place for the whole of the financial year to 30 June 2024, then the ongoing charges ratio ("OCR") would have been around 0.80%, rather than the reported 0.92%. The Board considers that this revised fee structure makes the Company more competitive.

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZGGDKZKGKZM
Date   Source Headline
10th Dec 20245:22 pmRNSTransaction in Own Shares
10th Dec 202411:56 amRNSNet Asset Value(s)
9th Dec 20245:18 pmRNSTransaction in Own Shares
9th Dec 20242:09 pmRNSGearing disclosure
9th Dec 202412:52 pmRNSNet Asset Value(s)
6th Dec 20245:08 pmRNSTransaction in Own Shares
6th Dec 20241:43 pmRNSNet Asset Value(s)
5th Dec 20245:30 pmRNSTransaction in Own Shares
5th Dec 20243:21 pmRNSMonth End Net Asset Value(s)
5th Dec 202412:21 pmRNSNet Asset Value(s)
4th Dec 20245:21 pmRNSTransaction in Own Shares
4th Dec 20241:06 pmRNSNet Asset Value(s)
3rd Dec 20245:30 pmRNSTransaction in Own Shares
3rd Dec 202412:11 pmRNSNet Asset Value(s)
2nd Dec 20245:32 pmRNSTransaction in Own Shares
2nd Dec 20243:04 pmRNSGearing disclosure
2nd Dec 202410:07 amRNSTotal Voting Rights
29th Nov 20245:12 pmRNSTransaction in Own Shares
29th Nov 202412:42 pmRNSNet Asset Value(s)
28th Nov 20245:11 pmRNSTransaction in Own Shares
28th Nov 202412:31 pmRNSNet Asset Value(s)
27th Nov 20245:12 pmRNSTransaction in Own Shares
27th Nov 202412:12 pmRNSNet Asset Value(s)
26th Nov 20245:11 pmRNSTransaction in Own Shares
26th Nov 202412:57 pmRNSNet Asset Value(s)
25th Nov 20245:23 pmRNSTransaction in Own Shares
25th Nov 20243:46 pmRNSGearing Disclosures
25th Nov 202412:40 pmRNSNet Asset Value(s)
22nd Nov 20245:17 pmRNSTransaction in Own Shares
22nd Nov 202412:20 pmRNSNet Asset Value(s)
21st Nov 20245:16 pmRNSTransaction in Own Shares
21st Nov 20243:30 pmRNSResult of AGM
21st Nov 202412:33 pmRNSNet Asset Value(s)
20th Nov 20245:18 pmRNSTransaction in Own Shares
20th Nov 202412:12 pmRNSNet Asset Value(s)
19th Nov 20245:26 pmRNSTransaction in Own Shares
19th Nov 20241:08 pmRNSNet Asset Value(s)
18th Nov 20245:18 pmRNSTransaction in Own Shares
18th Nov 20241:46 pmRNSGearing disclosure
18th Nov 20241:19 pmRNSNet Asset Value(s)
15th Nov 20245:34 pmRNSTransaction in Own Shares
15th Nov 20241:04 pmRNSNet Asset Value(s)
14th Nov 20245:23 pmRNSTransaction in Own Shares
14th Nov 202412:25 pmRNSNet Asset Value(s)
13th Nov 20245:23 pmRNSTransaction in Own Shares
13th Nov 202412:43 pmRNSNet Asset Value(s)
12th Nov 20245:17 pmRNSTransaction in Own Shares
12th Nov 202412:05 pmRNSNet Asset Value(s)
12th Nov 20248:56 amRNSPortfolio disclosure
11th Nov 20245:17 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.